Business · 14.11.2026 г.1 min read

CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List

Локален автоматски превод · Оригинален јазик на изворот

Illustration generated by Business News; it is not a source photograph.

Резиме

SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…

Оригинален јазик на изворот: PR Newswire — Global News ReleasesПрочитајте го оригиналот →

Related companies

STOCK
Open profile →Explore businesses on Business Maps →
Shanghai
Open profile →Explore businesses on Business Maps →
Shanghai
Open profile →Explore businesses on Business Maps →